People: Biomarin Pharmaceutical Inc (BMRN.OQ)

BMRN.OQ on NASDAQ Stock Exchange Global Select Market

116.32USD
4 May 2015
Change (% chg)

$0.40 (+0.35%)
Prev Close
$115.92
Open
$115.43
Day's High
$119.50
Day's Low
$114.64
Volume
405,924
Avg. Vol
493,422
52-wk High
$133.54
52-wk Low
$55.36

Search Stocks

Davis, G. Eric 

Mr. G. Eric Davis serves as Senior Vice President, General Counsel and Secretary of Biomarin Pharmaceutical Inc., since December 2005. He joined BioMarin in March 2004, and currently serves as our Senior Vice President, General Counsel and Secretary. From 2004 to December 2005, Mr. Davis served as our Vice President, General Counsel and Secretary. From 2000 to 2004, Mr. Davis worked in the San Francisco office of Paul Hastings LLP (formerly Paul, Hastings, Janofsky & Walker LLP), where he served on the firm’s national securities practice committee. Mr. Davis has represented public and private companies and venture capital and investment banking firms in a wide range of corporate and securities matters, mergers and acquisitions, strategic alliance matters, and intellectual property-related business transactions. His experience involves a variety of industries, including biotechnology and life sciences. Mr. Davis received a B.A. in political economy from the University of California, Berkeley, and a J.D. from the University of San Francisco School of Law.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
409,593 -- 1,729,010 2,708,210

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 37,854 1,773,060.00
Name Fiscal Year Total

Pierre Lapalme

--

Jean-Jacques Bienaime

11,364,000

Daniel Spiegelman

4,029,290

Jeff Ajer

2,657,540

Robert Baffi

3,645,440

Henry Fuchs

4,825,470
As Of  30 Dec 2014
Search Stocks